Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoni
Anastasios Stathis

Blood

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Blood|December 31, 2016
Staining the target: CD37 expression in lymphomasFrancesco Bertoni, Anastasios Stathis
Blood|August 12, 2017
Let's give BACH2 a breath of fresh airFrancesco Bertoni
Blood|March 19, 2016
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevanceEmanuele Zucca, Francesco Bertoni
Blood|September 30, 2025
The biology of marginal zone lymphoma subtypes: challenge and relevance of classificationCamille Laurent, Francesco Bertoni
Blood|February 8, 2017
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growthBojan Bujisic, Aude De Gassart, Rémy Tallant, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Blood|May 4, 2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphomaLuca Ceriani, Lisa Milan, Maurizio Martelli, et al.
Blood|February 17, 2018
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaValeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, et al.
Blood|June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaLuca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Blood|June 29, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaLuca Agnelli, Elisabetta Mereu, Elisa Pellegrino, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Blood|December 31, 2016
Staining the target: CD37 expression in lymphomasFrancesco Bertoni, Anastasios Stathis
Blood|August 12, 2017
Let's give BACH2 a breath of fresh airFrancesco Bertoni
Blood|March 19, 2016
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevanceEmanuele Zucca, Francesco Bertoni
Blood|September 30, 2025
The biology of marginal zone lymphoma subtypes: challenge and relevance of classificationCamille Laurent, Francesco Bertoni
Blood|February 8, 2017
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growthBojan Bujisic, Aude De Gassart, Rémy Tallant, et al.
Blood|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomasAlberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Blood|May 4, 2018
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphomaLuca Ceriani, Lisa Milan, Maurizio Martelli, et al.
Blood|February 17, 2018
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaValeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, et al.
Blood|June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaLuca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Blood|June 29, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaLuca Agnelli, Elisabetta Mereu, Elisa Pellegrino, et al.
Pageof 4